InterHealth Nutraceuticals Inc., a leading researcher, developer and marketer of branded nutraceutical ingredients, announced that it has acquired the assets of Chick Cart Inc., a Fort Smith, Ark.-based manufacturer of nutritional ingredients. Chick Cart is the holder of the primary patents related to the manufacture of undenatured type II collagen, which had previously been exclusively licensed to InterHealth for use in its UC-II® joint health product.
“The acquisition of Chick Cart provides InterHealth with increased control over the supply chain and intellectual property for our UC-II® product line. Chick Cart has built a best in class manufacturing platform and operating team, which are a welcome addition to the InterHealth team,” according to Paul Dijkstra, president and CEO of InterHealth.
The transaction marks the first acquisition completed by InterHealth since its acquisition by Kainos Capital in November 2013.
“InterHealth has a portfolio of branded functional ingredients supported by strong clinical data,” stated Andrew Rosen, managing partner of Kainos Capital. “UC-II is sold to a global customer base and continues to generate strong growth in the marketplace. This acquisition will better enable InterHealth to invest in additional production capacity to support the growth of UC-II going forward,” continued Rosen.